BridgeBio Oncology Therapeutics, Inc. (BBOT) — Defensive Interval Ratio
BridgeBio Oncology Therapeutics, Inc. (BBOT) has a Defensive Interval Ratio of 543 days as of December 2025. Defensive assets of $52.16 Million (cash $-, short-term investments $51.77 Million, receivables $386.00K) cover 543 days of daily cash needs of $96.00K/day. Check BridgeBio Oncology Therapeutics, Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
BridgeBio Oncology Therapeutics, Inc. Defensive Interval Ratio (2023–2025)
This chart shows how BridgeBio Oncology Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 543 days, meaning defensive assets of $52.16 Million can fund 543 days of operations without new revenue. Also explore BridgeBio Oncology Therapeutics, Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for BridgeBio Oncology Therapeutics, Inc. (2023–2025)
The table below presents the year-by-year Defensive Interval Ratio for BridgeBio Oncology Therapeutics, Inc. from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see BBOT market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 543 days | $52.16 Million | $96.00K/day | $- | $51.77 Million | ▼ -242342 days |
| 2024 | 242886 days | $124.78 Million | $513.74/day | $- | $124.78 Million | ▲ +242886 days |
| 2023 | 0 days | $0.00 | $1.09K/day | $- | $0.00 | — |